For example, in gliomas with a mutation in the isocitrate dehydrogenase (IDH) gene, that are characterized by lower malignancy [44], reduced activity of sphingosine kinase 1 has been demonstrated, resulting in decreased S1P levels [30]. This evidence concerns the gene IDH3A and central nervous system cancer.